Skip to main content
Log in

A selective somatostatin type-2 receptor agonist inhibits neointimal thickening and enhances endothelial cell growth and morphology following aortic balloon injury in the rabbit

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Somatostatin analogs have been shown to inhibit vascular smooth muscle cell (VSMC) proliferation and attenuate neointimal thickening following experimental balloon catheter injury. In this study, the effects of a selective agonist for the somatostatin receptor subtype 2, PRL-2486, on neointimal thickening and endothelial cell regrowth 2 weeks following balloon catheterization of male New Zealand White rabbits were determined. Rabbits treated 2 days prior to and 2 weeks after catheter injury with 10 μg/kg/day PRL-2486 (PRL-tx) had decreased I/M ratios (intimal area/medial area × 100; p < 0.05) but had no effect at lower (5 μg/kg/day) or higher (20 μg/kg/day) doses. PRL-tx had significantly decreased VSMC proliferation compared to untreated animals. PRL-tx increased endothelial regrowth by over 2-fold (p < 0.002) and improved endothelial cell morphology. Endothelial-dependent relaxation responses to acetylcholine were attenuated by catheter injury, and were not improved with PRL-tx. These data suggest that the PRL-2486-mediated inhibition of neointimal thickening exhibits a bell-shaped dose-response curve. This inhibition may be due in part to decreased VSMC proliferation, which may be a function of enhanced endothelial regrowth, but not the return of endothelium-dependent vascular function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bauters C, Isner JM: The biology of restenosis. Progr Cardiovasc Dis 40: 107-116, 1997

    Google Scholar 

  2. Clowes AW, Reidy MA, Clowes MM: Mechanisms of stenosis after arterial injury. Lab Invest 49: 208-215, 1983

    Google Scholar 

  3. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980

    Google Scholar 

  4. Haudenschild CC, Schwartz SM: Endothelial regeneration. II. Restitution of endothelial continuity. Lab Invest 41: 407-418, 1979

    Google Scholar 

  5. Stemerman MB, Spaet TH, Pitlick F, Cintron J, Lejnieks I, Tiell ML: The pattern of reendothelialization and intimal thickening. Am J Pathol 87: 125-142, 1997

    Google Scholar 

  6. Light JT, Bellan JA, Chen I-L, Longenecker LL, Murphy WA, Coy DH, Kadowitz PJ, McNamara DB: Angiopeptin enhances acetylcholineinduced relaxation and inhibits intimal hyperplasia after vascular injury. Am J Physiol 265: H1265-H1274, 1993

    Google Scholar 

  7. Santoian EC, Schneider JE, Gravanis MB, Foegh M, Tarazona N, Cipolla GD, King SB III: Angiopeptin inhibits intimal hyperplasia after angioplasty in porcine coronary arteries. Circulation 88: 11-14, 1993

    Google Scholar 

  8. Conte J, Foegh M, Calcagno D, Wallace R, Ramwell P: Peptide inhibition of proliferation following angioplasty in rabbits. Transplant Proc 21: 3686-3688, 1989

    Google Scholar 

  9. Danesi R, Del Tacca M: The effects of the somatostatin analog octreotide on angiogenesis in vitro. Metabolism 45: 49-50, 1996

    Google Scholar 

  10. Lundergan C, Foegh ML, Vargas R, Eufemio M, Bormes G, Kot PA, Ramwell PW: Inhibition of myointimal proliferation of the rat carotid artery by the peptides, angiopeptin and BIM 23034. Atherosclerosis 80: 49-55, 1989

    Google Scholar 

  11. Sakamoto H, Sakamaki T, Kanda T, Ito Y, Sumino H, Masuda H, Ohyama Y, Ono Z, Kurabayashi M, Kabayashi I, Nagai R: The somatostatin analog, octreotide, inhibits in vitro outgrowth of smooth muscle cells from canine coronary and carotid atherosclerotic plaque tissues. Res Commun Mol Pathol Pharmacol 101: 25-34, 1998

    Google Scholar 

  12. Vargas R, Wroblewska B, Rego A, Cathapermal S, Ramwell PW: Angiopeptin inhibits thymidine incorporation by explants of porcine coronary arteries. J Cardiovasc Pharmacol 29: 278-283, 1997

    Google Scholar 

  13. Foegh ML, Asotra S, Conte JV, Howell M, Kagan E, Verma K, Ramwell PW: Early inhibition of myointimal proliferation by angiopeptin following balloon catheter injury in the rabbit. J Vasc Surg 19: 1084-1091, 1994

    Google Scholar 

  14. Asahara T, Chen D, Tsurumi Y, Kearney M, Rossow S, Passeri J, Syme JF, Isner JM: Accelerated restitution of endothelial integrity and endothelial-derived function after phVEGF165 gene transfer. Circulation 94: 3291-3301, 1996

    Google Scholar 

  15. Thompson MM, Budd JS, Eady SL, Harley G, Early M, James RF, Bell PR: Platelet deposition after angioplasty is abolished by restoration of the endothelial cell monolayer. J Vasc Surg 19: 478-486, 1994

    Google Scholar 

  16. Schiller NK, Timothy AM, Chen I-L, Rice JC, Akers DL, Kadowitz PJ, McNamara DB. Endothelial cell regrowth and morphology after balloon catheter injury of alloxan-induced diabetic rabbits. Am J Physiol 277: H740-H748, 1999

    Google Scholar 

  17. Reisne T, Bell GI: Molecular biology of somatostatin receptors. Endocrine Rev 16: 427-442, 1995

    Google Scholar 

  18. Patel YC, Srikant CB: Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hhstr 1-5). Endocrinology 135: 2814-2817, 1994

    Google Scholar 

  19. Indolfi C, Esposito G, Di Lorenzo E, Rapacciuolo A, Feliciello A, Porcellini A, Avvedimento VE, Condorelli M, Chiariello M: Smooth muscle cell proliferation is proportional to the degree of balloon injury in a rat model of angioplasty. Circulation 92: 1230-1235, 1995

    Google Scholar 

  20. Garg UC, Hassid A: Nitric oxide-generating vasodilators and 8-bromocGMP inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. Clin Invest 83: 1774-1777, 1989

    Google Scholar 

  21. Palmer RM, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelial-derived relaxing factor. Nature 327: 524-526, 1987

    Google Scholar 

  22. Scott-Burden T, Vanhoutte PM: Regulation of smooth muscle cell growth. Texas Heart Inst J 21: 91-97, 1994

    Google Scholar 

  23. Bellan JA, Longenecker LL, Kadowitz PJ, McNamara DB: Selective and complete blockade of acetylcholine-induced relaxation in rabbit aortic rings by Nω-nitro-L-arginine but not by glybenclamide. Eur J Pharmacol 234: 273-276, 1993

    Google Scholar 

  24. Chen JC, Hsiang YN, Buchan AM: Somatostatin receptor expression in rat iliac arteries after balloon injury. J Invest Surg 10: 17-23, 1997

    Google Scholar 

  25. Leszcynki D, Josephs MD, Fournier RS, Foegh ML: Angiopeptin, the octapeptide analogue of somatostatin, decreases rat heart endothelial cell adhesiveness for mononuclear cells. Regul Pept 43: 131-140, 1993

    Google Scholar 

  26. Mooradian DL, Fernandes B, Diglio CA, Lester BR: Angiopeptin (BIM 23014C) inhibits vascular smooth muscle cell migration in vitro through a G-protein-mediated pathway and is associated with inhibition of adenylyl cyclase and cyclic AMP accumulation. J Cardiovasc Pharmacol 25: 611-618, 1995

    Google Scholar 

  27. Saroyan M, Roberts MP, Light JT, Chen I-L, Vaccarella MY, Bang DJ, Kvamme P, Singh S, Scalia SV, Kerstein MD, Kadowitz PJ, McNamara DB: Differential recovery of prostacyclin and endothelium-derived relaxing factor after vascular injury. Am J Physiol 262: H1449-H1457, 1992

    Google Scholar 

  28. Howell M, Orskov H, Frystyk J, Flyvbjerg A, Gronbaek H, Foegh M: Lanreotide, a somatostatin analogue, reduces insulin-like growth factor I accumulation in proliferating aortic tissue in rabbits in vivo. Eur J Endocrinol 130: 422-425, 1994

    Google Scholar 

  29. Frystyk J, Skjaaerbaek C, Alexander N, Emanuelsson H, Suryapranata H, Beyer H, Foegh M, Orskov H: Lanreotide reduces serum free and total insulin-like growth factor-1 after angioplasty. Circulation 94: 2456-2471, 1996

    Google Scholar 

  30. Yumi K, Fagin JA, Yamashita M, Fishbein MC, Shah PK, Kaul S, Niu W, Nilsson J, Cercek B: Direct effects of somatostatin analog Octreotide on insulin-like growth factor-I in the arterial wall. Lab Invest 76: 329-338, 1997

    Google Scholar 

  31. Arnqvist HJ, Bornfeldt KE, Chen Y, Lindstrom T: The insulin-like growth factor system in vascular smooth muscle: Interaction with insulin and growth factors. Metabolism 44: 58-66, 1995

    Google Scholar 

  32. Bornfeldt KE, Arnqvist HJ, Capron L: In vivo proliferation of rat vascular smooth muscle in relation to diabetes mellitus insulin-like growth factor I and insulin. Diabetologia 35: 104-108, 1992

    Google Scholar 

  33. Sidaway AN, Hakim FS, Jones BA, Norberto JM, Neville RF, Korman LY: Insulin-like growth factor-1 binding in injury-induced intimal hyperplasia of rabbit aorta. J Vasc Surg 23: 308-313, 1996

    Google Scholar 

  34. Yarden T, Ullrich A: Growth factor receptor tyrosine kinases. Annu Rev Biochem 57: 443-440, 1988

    Google Scholar 

  35. Schiller NK, McNamara DB: Balloon catheter vascular injury of the alloxan-induced diabetic rabbit: The role of insulin-like growth factor-1. Mol Cell Biochem 202: 159-167, 1999

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schiller, N.K., Timothy, A.M., Aurora, H.S. et al. A selective somatostatin type-2 receptor agonist inhibits neointimal thickening and enhances endothelial cell growth and morphology following aortic balloon injury in the rabbit. Mol Cell Biochem 240, 31–37 (2002). https://doi.org/10.1023/A:1020679809056

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020679809056

Navigation